Google-backed AI drug discovery startup Isomorphic Labs delays clinical trial timeline
This article is from: srnnews.com Jan 20 (Reuters) – Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on...
Read More















